Zhongmin Wang

Title: Innovations of Zhongmin Wang in Anti-Bacterial Applications

Introduction

Zhongmin Wang is an accomplished inventor based in Madison, AL (US). He has made significant contributions to the field of biotechnology, particularly in the development of anti-bacterial applications. His work focuses on enhancing the efficacy of proteins used in combating bacterial infections.

Latest Patents

Zhongmin Wang holds a patent for a Chalaropsis lysozyme protein and its method of use in anti-bacterial applications. This innovative lysozyme, referred to as Lysozyme Ch, features a corrected amino acid sequence that allows for the preparation of recombinant proteins with higher activity than those derived from the incorrect sequence. The methods associated with this lysozyme aim to reduce immunogenicity and increase its half-life. The Chalaropsis lysozyme is particularly effective in targeting resistant bacterial strains such as MRSA and VISA. Its applications extend to various settings, including hospitals and veterinary practices, and it serves as a potential defense against bioterror agents.

Career Highlights

Zhongmin Wang is currently employed at New Century Pharmaceuticals, Inc., where he continues to advance his research in the field of anti-bacterial solutions. His work has garnered attention for its potential to address critical health challenges posed by antibiotic-resistant bacteria.

Collaborations

Zhongmin collaborates with notable professionals in his field, including his coworker Daniel C. Carter. Their combined expertise contributes to the innovative research and development efforts at New Century Pharmaceuticals, Inc.

Conclusion

Zhongmin Wang's contributions to the field of biotechnology, particularly through his patented Chalaropsis lysozyme protein, highlight his commitment to addressing pressing health issues related to bacterial infections. His work exemplifies the importance of innovation in the fight against antibiotic resistance.